The ATTAIN-1 trial showed an average weight loss of 27.3 pounds (12.4%) over 72 weeks among participants who remained on Foundayo
Long-term treatment with a glucagon-like peptide-1 receptor agonist reduces ethanol intake in male and female rats
From its initial use in the treatment of type 2 diabetes to its expansion to 12 indications such as obesity, cardiovascular disease, chronic kidney disease, and metabolic dysfunction related fatty liver disease (MASLD), the annual sales of GLP-1 drugs exceeded 100 billion dollars, and its research and development funding reached a historical peak of 21.72 million dollars in 2025
Small molecule dipeptidylpeptidase IV inhibitors under investigation for diabetes mellitus therapy
Some tools even sync with wearables or glucose monitors, offering a deeper level of insight
A monthly Ozempic prescription at standard doses typically ranges from $900 to $1,300 when paying out-of-pocket, depending on dosage strength and pharmacy location